9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 19-21 July 19-21 2007, Sydney

HIV Treatment Bulletin - Vol. 8, No. 8/9, August-September 2007

Michael Dube, for NATAP.org

Overall there continues to be a progressive evolution of our understanding of the causes of lipodystrophy, dyslipidemia, cardiovascular disease, and other adverse effects of ART. While certainly there have been no major breakthroughs in management, the availability of agents with lesser effects on these parameters and a few therapeutic interventions have begun to be applied.

Webcasts of the oral presentations at Lipo are now available online at:

http://www.intmedpress.com/lipodystrophy/default.cfm?itemtypeid=15&title=Webcasts

Reports from this workshop include:

• Can nevirapine be safely substituted for other agents in those with high CD4 cell counts and virologic suppression?
• Do children with perinatally acquired HIV infection have problems with metabolism and body shape?
• The growth hormone releasing factor analogue tesamorelin (TH9507) reduces visceral fat, but what else does it do?
• Does diabetes have the same impact on cardiovascular risk in HIV-infected patients as it does in the general population?
• Can nucleoside RT inhibitors directly cause insulin resistance?
• Do dyslipidemia, insulin resistance, and body shape changes differ according to race/ethnicity?
• Is lipoatrophy associated with vascular dysfunction?

2007-08-10
IB070808-21

©2007. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.